期刊
CLINICAL & TRANSLATIONAL ONCOLOGY
卷 22, 期 5, 页码 647-662出版社
SPRINGER INTERNATIONAL PUBLISHING AG
DOI: 10.1007/s12094-019-02182-z
关键词
Colorectal cancer; Liver metastases; Surgery; Chemotherapy; Locoregional therapies; Consensus
类别
资金
- Spanish Society of Medical Oncology
- Spanish Association of Surgeons
- Spanish Society of Radiation Oncology
- Spanish Society of Vascular and Interventional Radiology
- Spanish Society of Nuclear Medicine and Molecular Imaging
Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% of patients with CRC will have metastases at the time of diagnosis, and more than 50% of patients with CRC develop metastatic disease during the course of their disease. A group of experts from the Spanish Society of Medical Oncology, the Spanish Association of Surgeons, the Spanish Society of Radiation Oncology, the Spanish Society of Vascular and Interventional Radiology, and the Spanish Society of Nuclear Medicine and Molecular Imaging met to discuss and provide a multidisciplinary consensus on the management of liver metastases in patients with CRC. The group defined the different scenarios in which the disease can present: fit or unfit patients with resectable liver metastases, patients with potential resectable liver metastases, and patients with unresectable liver metastases. Within each scenario, the different strategies and therapeutic approaches are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据